drugset / Trial / NCT01015495
Ranibizumab Therapy for Choroidal Neovascularization (CNV) Asociated With Angioid Streaks
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether injections of ranibizumab into the eye are safe and well tolerated when given to subjects in multiple doses.
Timeline
- Start
- 2009-12
- Primary completion
- 2010-12
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ranibizumab | Monoclonal antibody | 0.5 mg | Intravitreal |